Related Articles
Tanshinone IIA attenuates estradiol‑induced polycystic ovarian syndrome in mice by ameliorating FSHR expression in the ovary
hOGG1 gene polymorphisms and susceptibility to polycystic ovary syndrome
Cryptotanshinone alleviates polycystic ovary syndrome in rats by regulating the HMGB1/TLR4/NF‑κB signaling pathway
Reduced expression of follicle stimulating hormone receptor mRNA and protein in pregnancies complicated by pre‑eclampsia
Analyses of risk factors for polycystic ovary syndrome complicated with non-alcoholic fatty liver disease